Insufficient scRNA-seq data for expression of TH at single-cell level.
Insufficient scRNA-seq data for expression of TH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 91% | 10037.78 | 236 / 258 | 68% | 1942.05 | 157 / 230 |
bladder | 86% | 114.10 | 18 / 21 | 50% | 8.80 | 250 / 504 |
uterus | 72% | 30.81 | 122 / 170 | 31% | 2.08 | 144 / 459 |
ovary | 91% | 57.90 | 164 / 180 | 9% | 0.26 | 39 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 246.33 | 1 / 1 |
esophagus | 71% | 36.36 | 1026 / 1445 | 18% | 0.72 | 33 / 183 |
liver | 80% | 33.07 | 180 / 226 | 2% | 0.07 | 8 / 406 |
brain | 73% | 1016.83 | 1939 / 2642 | 5% | 0.16 | 38 / 705 |
stomach | 44% | 22.02 | 158 / 359 | 28% | 0.89 | 80 / 286 |
intestine | 30% | 9.43 | 292 / 966 | 35% | 1.06 | 184 / 527 |
spleen | 61% | 16.17 | 146 / 241 | 0% | 0 | 0 / 0 |
pancreas | 37% | 9.24 | 122 / 328 | 21% | 3.55 | 38 / 178 |
skin | 55% | 29.36 | 990 / 1809 | 3% | 0.08 | 14 / 472 |
prostate | 55% | 29.62 | 134 / 245 | 3% | 0.07 | 15 / 502 |
kidney | 36% | 10.67 | 32 / 89 | 1% | 0.08 | 12 / 901 |
breast | 20% | 4.09 | 94 / 459 | 15% | 0.68 | 168 / 1118 |
thymus | 21% | 4.52 | 138 / 653 | 7% | 0.12 | 43 / 605 |
adipose | 22% | 5.50 | 267 / 1204 | 0% | 0 | 0 / 0 |
lung | 12% | 2.37 | 70 / 578 | 9% | 0.58 | 102 / 1155 |
heart | 8% | 2.02 | 73 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 6% | 1.66 | 78 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.07 | 4 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.83 | 2 / 45 |
muscle | 3% | 1.77 | 21 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.13 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009651 | Biological process | response to salt stress |
GO_0014823 | Biological process | response to activity |
GO_0042416 | Biological process | dopamine biosynthetic process |
GO_0042462 | Biological process | eye photoreceptor cell development |
GO_0052314 | Biological process | phytoalexin metabolic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0042755 | Biological process | eating behavior |
GO_0010043 | Biological process | response to zinc ion |
GO_0001963 | Biological process | synaptic transmission, dopaminergic |
GO_0007613 | Biological process | memory |
GO_0035176 | Biological process | social behavior |
GO_0016137 | Biological process | glycoside metabolic process |
GO_0007626 | Biological process | locomotory behavior |
GO_0015842 | Biological process | aminergic neurotransmitter loading into synaptic vesicle |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0033076 | Biological process | isoquinoline alkaloid metabolic process |
GO_0043434 | Biological process | response to peptide hormone |
GO_0048596 | Biological process | embryonic camera-type eye morphogenesis |
GO_0007612 | Biological process | learning |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0071287 | Biological process | cellular response to manganese ion |
GO_0006665 | Biological process | sphingolipid metabolic process |
GO_0043473 | Biological process | pigmentation |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0007617 | Biological process | mating behavior |
GO_0051412 | Biological process | response to corticosterone |
GO_0008016 | Biological process | regulation of heart contraction |
GO_1990384 | Biological process | hyaloid vascular plexus regression |
GO_0003007 | Biological process | heart morphogenesis |
GO_0007601 | Biological process | visual perception |
GO_0032355 | Biological process | response to estradiol |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0035902 | Biological process | response to immobilization stress |
GO_0035900 | Biological process | response to isolation stress |
GO_0045471 | Biological process | response to ethanol |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0042418 | Biological process | epinephrine biosynthetic process |
GO_0071312 | Biological process | cellular response to alkaloid |
GO_0006585 | Biological process | dopamine biosynthetic process from tyrosine |
GO_0042214 | Biological process | terpene metabolic process |
GO_0018963 | Biological process | phthalate metabolic process |
GO_0009416 | Biological process | response to light stimulus |
GO_0001975 | Biological process | response to amphetamine |
GO_0045472 | Biological process | response to ether |
GO_0007507 | Biological process | heart development |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0042421 | Biological process | norepinephrine biosynthetic process |
GO_0031667 | Biological process | response to nutrient levels |
GO_0046684 | Biological process | response to pyrethroid |
GO_0009635 | Biological process | response to herbicide |
GO_0042745 | Biological process | circadian sleep/wake cycle |
GO_0071316 | Biological process | cellular response to nicotine |
GO_0021987 | Biological process | cerebral cortex development |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0043195 | Cellular component | terminal bouton |
GO_0043005 | Cellular component | neuron projection |
GO_0033162 | Cellular component | melanosome membrane |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0030425 | Cellular component | dendrite |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005739 | Cellular component | mitochondrion |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0005790 | Cellular component | smooth endoplasmic reticulum |
GO_0043204 | Cellular component | perikaryon |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0004511 | Molecular function | tyrosine 3-monooxygenase activity |
GO_0035240 | Molecular function | dopamine binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0019825 | Molecular function | oxygen binding |
GO_0008199 | Molecular function | ferric iron binding |
GO_0005515 | Molecular function | protein binding |
GO_0034617 | Molecular function | tetrahydrobiopterin binding |
GO_0016597 | Molecular function | amino acid binding |
Gene name | TH |
Protein name | Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH) Tyrosine hydroxylase Tyrosine hydroxylase (EC 1.14.16.2) TH protein |
Synonyms | TYH |
Description | FUNCTION: Catalyzes the conversion of L-tyrosine to L-dihydroxyphenylalanine (L-Dopa), the rate-limiting step in the biosynthesis of cathecolamines, dopamine, noradrenaline, and adrenaline. Uses tetrahydrobiopterin and molecular oxygen to convert tyrosine to L-Dopa . In addition to tyrosine, is able to catalyze the hydroxylation of phenylalanine and tryptophan with lower specificity (By similarity). Positively regulates the regression of retinal hyaloid vessels during postnatal development (By similarity). .; FUNCTION: [Isoform 5]: Lacks catalytic activity. .; FUNCTION: [Isoform 6]: Lacks catalytic activity. . |
Accessions | ENST00000416223.5 ENST00000333684.9 [P07101-6] Q7KZ39 ENST00000381175.5 [P07101-2] ENST00000412076.1 Q7KZ36 E7EQI0 Q7KZ44 H0Y677 P78428 H0Y670 Q7KZ38 P07101 ENST00000381178.5 [P07101-1] F8W8M5 Q9UQ57 ENST00000352909.8 [P07101-3] ENST00000324155.8 ENST00000381168.7 |